NOT KNOWN FACTUAL STATEMENTS ABOUT MOLNUPIRAVIR

Pharmacological inhibition with the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also called FRAP-related protein (FRP1)) has emerged being a promising technique for cancer procedure that exploits artificial lethal interactions with proteins linked to DNA injury repair, overcomes resistance to other therapies and